Company Exact Sciences Corporation

Equities

EXAS

US30063P1057

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Exact Sciences Corporation

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Bio Diagnostics & Testing

Real-time Estimate Cboe BZX Other stock markets 11:16:15 2024-04-19 am EDT			5-day change	1st Jan Change
61.7 ^USD	-2.80%		-13.53%	-16.62%

Apr. 17	Exact Sciences Corporation announced that it has received $266.75 million in funding	CI
Apr. 15	Sector Update: Health Care Stocks Advance Premarket Monday	MT

Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Companyâs products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, and OncoExTra Test. The Companyâs flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patientâs breast tumor tissue.

Number of employees: 6,550

USD in Million	2022	Weight	2023	Weight	Delta
Screening 74.6 %	1,425	68.4 %	1,865	74.6 %	+30.88%
Precision Oncology 25.2 %	601	28.9 %	629	25.2 %	+4.59%
COVID-19 Testing 0.2 %	58	2.8 %	6	0.2 %	-89.75%

USD in Million	2022	Weight	2023	Weight	Delta
United States 93.9 %	1,967	94.4 %	2,346	93.9 %	+19.32%
Non-United States 6.1 %	118	5.6 %	153	6.1 %	+30.18%

Managers	Title	Age	Since
Kevin Conroy CEO	Chief Executive Officer	58	09-03-17
Paul Limburg CTO	Chief Tech/Sci/R&D Officer	-	18-03-05
Jorge Garces CTO	Chief Tech/Sci/R&D Officer	52	21-01-31
Frederick Baehner CTO	Chief Tech/Sci/R&D Officer	-	18-12-31
Tomasz Beer CTO	Chief Tech/Sci/R&D Officer	-	21-12-31
D. Coward BRD	Director/Board Member	59	14-12-31
Kristen Weiler SAM	Sales & Marketing	-	17-12-31
Ana Hooker PRN	Corporate Officer/Principal	58	12-12-31
Kyle Stacey AUD	Comptroller/Controller/Auditor	-	08-12-31
James Herriott LAW	General Counsel	44	17-12-31

Members of the board	Title	Age	Since
D. Coward BRD	Director/Board Member	59	14-12-31
Kevin Conroy CEO	Chief Executive Officer	58	09-03-17
Freda Lewis-Hall BRD	Director/Board Member	68	20-04-21
Timothy Scannell BRD	Director/Board Member	60	23-10-30
Daniel Levangie BRD	Director/Board Member	74	10-07-15
Katherine Napier BRD	Director/Board Member	69	09-04-23
Paul Clancy BRD	Director/Board Member	62	21-03-17
Pierre Jacquet BRD	Director/Board Member	57	19-07-24
James Doyle BRD	Director/Board Member	78	14-07-23
Kathleen Sebelius BRD	Director/Board Member	74	19-03-02

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	181,530,967	179,701,553 ( 98.99 %)	0	98.99 %

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 9.673 %	17,559,751	9.673 %	1 213 M $
JPMorgan Investment Management, Inc. 9.186 %	16,676,200	9.186 %	1 152 M $
Wellington Management Co. LLP 5.663 %	10,280,814	5.663 %	710 M $
BlackRock Advisors LLC 4.790 %	8,694,755	4.790 %	600 M $
Capital Research & Management Co. (World Investors) 4.114 %	7,468,145	4.114 %	516 M $
STATE STREET CORPORATION 2.766 %	5,020,742	2.766 %	347 M $
Artisan Partners Holdings LP 2.463 %	4,470,278	2.463 %	309 M $
Baillie Gifford & Co. 2.075 %	3,767,055	2.075 %	260 M $
ARK Investment Management LLC 1.800 %	3,267,648	1.800 %	226 M $
T. Rowe Price Investment Management, Inc. 1.626 %	2,951,302	1.626 %	204 M $

EXACT Sciences Corp.

5505 Endeavor Lane

53719, Madison

+608 284 5700

http://www.exactsciences.com

address Exact Sciences Corporation(EXAS)

Name	Category and Sector
GENOMIC HEALTH, INC.	Medical Specialties

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

63.48 USD

Average target price

89.27 USD

Spread / Average Target

+40.62%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
EXACT SCIENCES CORPORATION	-16.62%	11.52B
IOVANCE BIOTHERAPEUTICS, INC.	+39.94%	3.27B
BGI GENOMICS CO., LTD.	-19.90%	2.02B
VERACYTE, INC.	-30.06%	1.44B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+12.21%	1.01B
SEEGENE, INC.	-6.11%	719M
CAREDX, INC	-31.79%	418M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-51.73%	339M
CURIOX BIOSYSTEMS CO., LTD	-3.18%	284M
HLB BIOSTEP CO.,LTD.	+24.60%	240M

Bio Diagnostics & Testing